Sotera Health Quarterly Income Statements Chart
Quarterly
|
Annual
Sotera Health Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues: | |||||||||||||||||||
service | 257,244,000 | 223,940,000 | 238,795,000 | 238,790,000 | 237,756,000 | 226,481,000 | 237,918,000 | 227,120,000 | 226,050,000 | 214,510,000 | 220,377,000 | 216,704,000 | 221,529,000 | 206,218,000 | 207,594,000 | 200,499,000 | 208,710,000 | 188,698,000 | |
product | 37,097,000 | 30,583,000 | 51,408,000 | 46,678,000 | 38,838,000 | 21,695,000 | 72,321,000 | 36,057,000 | 29,232,000 | 6,080,000 | 31,213,000 | 32,000,000 | 45,110,000 | 30,536,000 | 33,655,000 | 25,665,000 | 43,207,000 | 23,450,000 | |
total net revenues | 294,341,000 | 254,523,000 | 290,203,000 | 285,468,000 | 276,594,000 | 248,176,000 | 310,239,000 | 263,177,000 | 255,282,000 | 220,590,000 | 251,590,000 | 248,704,000 | 266,639,000 | 236,754,000 | 241,249,000 | 226,164,000 | 251,917,000 | 212,148,000 | |
cost of revenues: | |||||||||||||||||||
total cost of revenues | 127,720,000 | 119,091,000 | 125,838,000 | 127,444,000 | 123,803,000 | 121,061,000 | 130,156,000 | 117,193,000 | 115,694,000 | 109,087,000 | 109,870,000 | 112,691,000 | 116,243,000 | 107,879,000 | 107,296,000 | 100,578,000 | 108,156,000 | 96,776,000 | |
gross profit | 166,621,000 | 135,432,000 | 164,365,000 | 158,024,000 | 152,791,000 | 127,115,000 | 180,083,000 | 145,984,000 | 139,588,000 | 111,503,000 | 141,720,000 | 136,013,000 | 150,396,000 | 128,875,000 | 133,953,000 | 125,586,000 | 143,761,000 | 115,372,000 | |
yoy | 9.05% | 6.54% | -8.73% | 8.25% | 9.46% | 14.00% | 27.07% | 7.33% | -7.19% | -13.48% | 5.80% | 8.30% | 4.62% | 11.70% | |||||
qoq | 23.03% | -17.60% | 4.01% | 3.42% | 20.20% | -29.41% | 23.36% | 4.58% | 25.19% | -21.32% | 4.20% | -9.56% | 16.70% | -3.79% | 6.66% | -12.64% | 24.61% | ||
gross margin % | |||||||||||||||||||
selling, general and administrative expenses | 68,893,000 | 63,061,000 | 61,837,000 | 62,009,000 | 60,575,000 | 58,209,000 | 60,358,000 | 54,112,000 | 60,287,000 | 61,910,000 | 65,949,000 | 57,091,000 | 63,132,000 | 59,542,000 | 51,827,000 | 44,038,000 | 49,828,000 | 52,465,000 | |
amortization of intangible assets | 9,298,000 | 15,327,000 | 15,382,000 | 15,508,000 | 15,417,000 | 15,732,000 | 15,701,000 | 15,774,000 | 16,097,000 | 16,227,000 | 15,603,000 | 15,727,000 | 15,769,000 | 15,841,000 | 15,700,000 | 15,877,000 | 15,661,000 | 16,543,000 | |
illinois eo litigation settlements | 34,000,000 | ||||||||||||||||||
interest expense | 40,651,000 | 40,876,000 | 40,960,000 | 41,572,000 | 40,388,000 | 41,771,000 | 42,653,000 | 40,627,000 | 30,728,000 | 28,870,000 | 32,269,000 | 23,427,000 | 14,044,000 | 10,404,000 | 15,607,000 | 18,140,000 | 19,163,000 | 21,282,000 | |
loss on refinancing of debt | 80,000 | 8,000 | 70,000 | 23,400,000 | |||||||||||||||
foreign exchange gain | 627,000 | 289,000 | 465,000 | -65,000 | 756,000 | 76,000 | 578,000 | ||||||||||||
other income | -5,825,000 | -241,000 | -1,222,000 | -2,835,000 | -1,520,000 | 961,000 | -4,072,000 | 427,000 | -2,474,000 | -1,253,000 | -2,246,000 | -1,713,000 | 485,000 | -2,967,000 | -7,854,000 | -693,000 | -2,764,000 | -3,890,000 | |
income before income taxes | 18,897,000 | -14,823,000 | 44,964,000 | 42,754,000 | 15,142,000 | 11,014,000 | 65,670,000 | 470,000 | 34,485,000 | 5,402,000 | -378,502,000 | 42,016,000 | 48,108,000 | 45,267,000 | 58,734,000 | 41,103,000 | 61,797,000 | 14,082,000 | |
benefit from income taxes | 10,935,000 | 9,208,750 | 25,756,000 | 6,388,000 | 4,691,000 | 6,915,500 | 14,130,000 | 10,972,000 | 2,560,000 | 12,310,500 | 16,926,000 | 17,690,000 | 14,626,000 | ||||||
net income | 7,962,000 | -13,260,000 | 12,323,000 | 16,998,000 | 8,754,000 | 6,323,000 | 38,681,000 | -13,660,000 | 23,513,000 | 2,842,000 | -319,719,000 | 25,090,000 | 30,418,000 | 30,641,000 | 35,997,000 | 27,444,000 | 42,615,000 | 11,065,000 | |
yoy | -9.05% | -309.71% | -68.14% | -224.44% | -62.77% | 122.48% | -112.10% | -154.44% | -22.70% | -90.72% | -988.18% | -8.58% | -28.62% | 176.92% | |||||
qoq | -160.05% | -207.60% | -27.50% | 94.17% | 38.45% | -83.65% | -383.17% | -158.10% | 727.34% | -100.89% | -1374.29% | -17.52% | -0.73% | -14.88% | 31.17% | -35.60% | 285.13% | ||
net income margin % | |||||||||||||||||||
other comprehensive income net of tax: | |||||||||||||||||||
pension and post-retirement benefits | 71,000 | 10,000 | 8,456,000 | -137,000 | 30,000 | 113,000 | -10,347,000 | -126,000 | 18,000 | -51,000 | 19,467,000 | 1,065,000 | 532,000 | -274,000 | 25,849,000 | 1,383,000 | -421,000 | -249,000 | |
interest rate derivatives | -1,123,000 | -772,000 | 662,000 | -4,016,000 | -2,461,000 | 419,000 | -8,734,000 | -1,714,000 | 4,002,000 | -9,251,000 | 2,174,000 | 9,408,000 | 3,178,000 | 6,179,000 | |||||
foreign currency translation | 82,217,000 | 19,560,000 | -92,750,000 | 24,931,000 | -23,110,000 | -27,706,000 | 40,539,000 | -32,996,000 | 21,374,000 | 11,257,000 | 35,707,000 | -69,460,000 | -46,038,000 | 14,975,000 | -3,867,000 | -29,867,000 | 20,425,000 | -3,086,000 | |
comprehensive income | 89,127,000 | 5,538,000 | -71,309,000 | 37,776,000 | -16,787,000 | -20,851,000 | 60,139,000 | -48,496,000 | 48,907,000 | 4,797,000 | -262,371,000 | -33,897,000 | -11,910,000 | 51,521,000 | 58,383,000 | -1,040,000 | 62,619,000 | 7,730,000 | |
earnings per share: | |||||||||||||||||||
basic | 0.03 | -0.05 | 0.05 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 | 0.01 | -1.14 | 0.09 | 0.11 | 0.11 | 0.12 | 0.1 | 0.15 | 0.04 | |
diluted | 0.03 | -0.05 | 0.05 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 | 0.01 | -1.14 | 0.09 | 0.11 | 0.11 | 0.12 | 0.1 | 0.15 | 0.04 | |
weighted-average number of shares outstanding: | |||||||||||||||||||
basic | 283,933 | 283,558 | 282,784 | 283,059 | 282,894 | 281,913 | 281,008 | 281,105 | 280,893 | 280,691 | 280,096 | 280,142 | 279,990 | 279,829 | 279,228 | 279,381 | 279,078 | 278,827 | |
diluted | 285,756 | 283,558 | 284,906 | 285,564 | 284,541 | 284,062 | 283,222 | 281,105 | 283,147 | 282,977 | 280,096 | 280,172 | 280,171 | 279,908 | 279,382 | 279,560 | 279,214 | 278,968 | |
illinois eo litigation settlement | 30,943,000 | ||||||||||||||||||
benefit for income taxes | -1,563,000 | 22,737,000 | 13,659,000 | 19,182,000 | 3,017,000 | ||||||||||||||
operating expenses: | |||||||||||||||||||
total operating expenses | 77,219,000 | 77,517,000 | 75,992,000 | 73,941,000 | 76,059,000 | 69,886,000 | 76,384,000 | 78,137,000 | 81,552,000 | 72,818,000 | 78,901,000 | 75,383,000 | 67,527,000 | 59,915,000 | 65,489,000 | 69,008,000 | |||
operating income | 87,146,000 | 80,507,000 | 76,799,000 | 53,174,000 | 104,024,000 | 76,098,000 | 63,204,000 | 33,366,000 | 60,168,000 | 63,195,000 | 71,495,000 | 53,492,000 | 66,426,000 | 65,671,000 | 78,272,000 | 46,364,000 | |||
yoy | -16.23% | 5.79% | 21.51% | 59.37% | 72.89% | 20.42% | -11.60% | -37.62% | -9.42% | -3.77% | -8.66% | 15.37% | |||||||
qoq | 8.25% | 4.83% | 44.43% | -48.88% | 36.70% | 20.40% | 89.43% | -44.55% | -4.79% | -11.61% | 33.66% | -19.47% | 1.15% | -16.10% | 68.82% | ||||
operating margin % | |||||||||||||||||||
georgia eo litigation settlement | 35,000,000 | ||||||||||||||||||
foreign exchange (gain) loss | -559,250 | -1,054,000 | -611,000 | -572,000 | 96,500 | -426,000 | -125,500 | -535,000 | -755,000 | ||||||||||
impairment of investment in unconsolidated affiliate | 9,613,000 | ||||||||||||||||||
foreign exchange loss | 347,000 | 788,000 | |||||||||||||||||
loss on extinguishment of debt | 4,000 | 6,365,000 | 14,312,000 | ||||||||||||||||
less: net income attributable to noncontrolling interests | 16,000 | 223,000 | |||||||||||||||||
net income attributable to sotera health company | -319,719,000 | 25,090,000 | 30,418,000 | 30,641,000 | 35,997,000 | 27,444,000 | 42,599,000 | 10,842,000 | |||||||||||
less: comprehensive income attributable to noncontrolling interests | 326,000 | 208,000 | |||||||||||||||||
comprehensive income attributable to sotera health company | -262,371,000 | -33,897,000 | -11,910,000 | 51,521,000 | 58,383,000 | -1,040,000 | 62,293,000 | 7,522,000 | |||||||||||
interest rate swaps |
We provide you with 20 years income statements for Sotera Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Sotera Health stock. Explore the full financial landscape of Sotera Health stock with our expertly curated income statements.
The information provided in this report about Sotera Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.